Hikma Pharmaceuticals PLC (FRA:H5P)

Hikma Pharmaceuticals Statistics

Total Valuation

FRA:H5P has a market cap or net worth of EUR 3.97 billion. The enterprise value is 5.08 billion.

Market Cap	3.97B
Enterprise Value	5.08B

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Current Share Class	221.45M
Shares Outstanding	n/a
Shares Change (YoY)	-0.18%
Shares Change (QoQ)	-0.36%
Owned by Insiders (%)	2.57%
Owned by Institutions (%)	60.38%
Float	154.18M

Valuation Ratios

The trailing PE ratio is 12.56 and the forward PE ratio is 9.02.

PE Ratio	12.56
Forward PE	9.02
PS Ratio	1.45
PB Ratio	1.83
P/TBV Ratio	3.53
P/FCF Ratio	12.84
P/OCF Ratio	8.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.90, with an EV/FCF ratio of 16.42.

EV / Earnings	16.07
EV / Sales	1.90
EV / EBITDA	7.90
EV / EBIT	10.54
EV / FCF	16.42

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.61.

Current Ratio	1.24
Quick Ratio	0.65
Debt / Equity	0.61
Debt / EBITDA	2.01
Debt / FCF	4.29
Interest Coverage	8.17

Financial Efficiency

Return on equity (ROE) is 15.38% and return on invested capital (ROIC) is 9.43%.

Return on Equity (ROE)	15.38%
Return on Assets (ROA)	6.97%
Return on Invested Capital (ROIC)	9.43%
Return on Capital Employed (ROCE)	16.58%
Revenue Per Employee	288,255
Profits Per Employee	33,253
Employee Count	9,500
Asset Turnover	0.62
Inventory Turnover	1.82

Taxes

In the past 12 months, FRA:H5P has paid 75.78 million in taxes.

Income Tax	75.78M
Effective Tax Rate	19.26%

Stock Price Statistics

The stock price has decreased by -23.93% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.93%
50-Day Moving Average	19.53
200-Day Moving Average	22.26
Relative Strength Index (RSI)	38.59
Average Volume (20 Days)	61

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:H5P had revenue of EUR 2.74 billion and earned 315.91 million in profits. Earnings per share was 1.42.

Revenue	2.74B
Gross Profit	1.18B
Operating Income	493.87M
Pretax Income	393.39M
Net Income	315.91M
EBITDA	650.55M
EBIT	493.87M
Earnings Per Share (EPS)	1.42

Balance Sheet

The company has 200.95 million in cash and 1.33 billion in debt, giving a net cash position of -1.13 billion.

Cash & Cash Equivalents	200.95M
Total Debt	1.33B
Net Cash	-1.13B
Net Cash Per Share	n/a
Equity (Book Value)	2.17B
Book Value Per Share	9.76
Working Capital	426.60M

Cash Flow

In the last 12 months, operating cash flow was 448.74 million and capital expenditures -139.65 million, giving a free cash flow of 309.09 million.

Operating Cash Flow	448.74M
Capital Expenditures	-139.65M
Free Cash Flow	309.09M
FCF Per Share	n/a

Margins

Gross margin is 43.03%, with operating and profit margins of 18.03% and 11.54%.

Gross Margin	43.03%
Operating Margin	18.03%
Pretax Margin	14.37%
Profit Margin	11.54%
EBITDA Margin	23.76%
EBIT Margin	18.03%
FCF Margin	11.29%

Dividends & Yields

This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 4.20%.

Dividend Per Share	0.75
Dividend Yield	4.20%
Dividend Growth (YoY)	3.47%
Years of Dividend Growth	6
Payout Ratio	47.71%
Buyback Yield	0.18%
Shareholder Yield	4.39%
Earnings Yield	7.96%
FCF Yield	7.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:H5P has an Altman Z-Score of 2.8 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.8
Piotroski F-Score	5